DexCom, Inc. (DXCM) Stock

DexCom, Inc. (DXCM) is a Healthcare stock trading at $72.45 (as of 2026-06-18), with a market capitalization of $28.45B and a trailing P/E of 32.3. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

DexCom, Inc. designs, develops, and markets continuous glucose monitoring systems, including integrated CGM offerings and related software and remote monitoring capabilities. Its products are used by people with diabetes and by healthcare providers, and the company also supports third-party integration through an API for real-time CGM data.

Valuation — source: SEC EDGAR (first-party)
Price$72.45
Market Cap$28.45B
P/E Ratio32.3
EV / EBITDA21.6
Price / Book9.84
Price / Sales6.04
DCF Value (model)$73.01
DCF Upside vs Price0.8%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$4.66B
Net Margin17.9%
Return on Equity31.5%
Current Ratio1.95
Revenue Growth (YoY)15.0%
EPS Growth (YoY)92.6%
FCF Growth (YoY)363.8%
Financial Health — source: SEC EDGAR
Altman Z-Score6.76 (safe)
Valuation vs Sector & Industry
Stock P/E32.3
Sector P/E (Healthcare)21.0
Industry P/E (Medical Equipment)31.7
vs Sector54.3%
vs Industry1.9%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderVANGUARD GROUP INC ($3.26B)
Institutional Holders Tracked10
Congressional Trades (recent)10
Company
SectorHealthcare
IndustryMedical Equipment
CEOJacob Steven Leach
Employees10,200
CountryUS
IPO Date2005-04-14

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • Alcon Inc. (ALC)
  • ResMed Inc. (RMD)
  • GE HealthCare Technologies Inc. (GEHC)
  • Medline Inc. (MDLN)
  • Mettler-Toledo International Inc. (MTD)
  • STERIS plc (STE)
  • Illumina, Inc. (ILMN)
  • Insulet Corporation (PODD)
DXCM earnings history · DXCM institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.